| Authors: |
Kurz SC; Department of Neurology & Interdisciplinary Neuro-Oncology, University Hospitals Tübingen, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen, Germany., Zan E; Department of Radiology, Weill Cornell Medicine, New York, New York., Cordova C; Cleveland Clinic Foundation Taussig Cancer Center, Cleveland, Ohio., Troxel AB; Department of Population Health, New York University Grossman School of Medicine, New York, New York., Barbaro M; Brain and Spine Tumor Center, Laura and Isaac Perlmutter Cancer Center at NYU Langone Health, New York, New York., Silverman JS; Brain and Spine Tumor Center, Laura and Isaac Perlmutter Cancer Center at NYU Langone Health, New York, New York.; Department of Radiation Oncology, New York University Grossman School of Medicine, New York, New York., Snuderl M; Brain and Spine Tumor Center, Laura and Isaac Perlmutter Cancer Center at NYU Langone Health, New York, New York.; Department of Pathology, New York University Grossman School of Medicine, New York, New York., Zagzag D; Brain and Spine Tumor Center, Laura and Isaac Perlmutter Cancer Center at NYU Langone Health, New York, New York.; Department of Pathology, New York University Grossman School of Medicine, New York, New York., Kondziolka D; Brain and Spine Tumor Center, Laura and Isaac Perlmutter Cancer Center at NYU Langone Health, New York, New York.; Department of Neurosurgery, New York University Grossman School of Medicine, New York, New York., Golfinos JG; Brain and Spine Tumor Center, Laura and Isaac Perlmutter Cancer Center at NYU Langone Health, New York, New York.; Department of Neurosurgery, New York University Grossman School of Medicine, New York, New York., Chi AS; Alterome Therapeutics, San Diego, California., Sulman EP; Brain and Spine Tumor Center, Laura and Isaac Perlmutter Cancer Center at NYU Langone Health, New York, New York.; Department of Radiation Oncology, New York University Grossman School of Medicine, New York, New York. |
